7Baggers

Butterfly Network, Inc
(NYSE:BFLY) 

BFLY stock logo

Butterfly Network, Inc., a digital health company, develops, manufactures, and commercializes ultrasound imaging solutions in the United States and internationally. It offers Butterfly iQ, a handheld and single-probe whole body ultrasound system; and Butterfly iQ+, a point-of-care ultrasound imaging...

Founded: 2011
Founder: Jonathan Rothberg, Nevada Sanchez, Tyler Ralston 
CEO: Jonathan M. Rothberg  
Sector: Healthcare
Industry: Medical Devices
Medical Devices
Share this website to your friends
• Market Cap:
• Exchange:
• Shs Outstanding:
• Employees:
• Beta:
• Return on Equity (ROE) ttm:
• Return on Assets (ROA) ttm:
• EPS ttm:
• Book value per Share:
• Cash per Share:
• Current ast per Share:
• P/E ttm:
• P/E forward:
• P/E ttm high:
• P/E ttm low:
• P/S ttm:
• P/B ttm:
• P/FCF ttm:
• PEG ratio:
• Cash Ratio ttm:
• Quick Ratio ttm:
• Current Ratio ttm:
• Gross Mgn ttm:
• EBITDA Mgn ttm:
• Operating Mgn ttm:
• Net Income Mgn ttm:
• Trailing Div yield:
• Forward Div yield:
• Payout Ratio ttm:
• Ex-Dividend date:
• Target Price High:
• Target Price Low:
• Target Price Mean:
• Number of Analysts:
• Debt Ratio ttm:
• Debt to Equity ttm:
• Total Net Debt:
At a glance:
Bull Thesis:
Bear Thesis:
Main Competitors:
Moat:
Income Statements:
Quarterly
Annual
    Unit: USD2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-09-30 
                          
      revenue:
    		                      
      product
    		14,653,000 18,102,000 14,556,000 16,621,000 14,164,000 14,722,000 13,538,000 14,648,000 11,291,000 10,162,000 8,753,000 12,273,000 8,848,000 12,656,000 13,164,000 13,429,000 11,014,000 14,413,000 10,848,000 13,012,000 9,595,000  
      software and other services
    		11,877,000 13,412,000 6,933,000 6,762,000 7,061,000 7,629,000 7,023,000 6,839,000 6,365,000 6,354,000 6,668,000 6,214,000 6,628,000 6,327,000 6,454,000        
      total revenue
    		26,530,000 31,514,000 21,489,000 23,383,000 21,225,000 22,351,000 20,561,000 21,487,000 17,656,000 16,516,000 15,421,000 18,487,000 15,476,000 18,983,000 19,618,000 19,215,000 15,574,000 18,987,000 14,621,000 16,513,000 12,443,000  
      yoy
    		24.99% 41.00% 4.51% 8.82% 20.21% 35.33% 33.33% 16.23% 14.09% -13.00% -21.39% -3.79% -0.63% -0.02% 34.18% 16.36% 25.16%      
      qoq
    		-15.82% 46.65% -8.10% 10.17% -5.04% 8.71% -4.31% 21.70% 6.90% 7.10% -16.58% 19.46% -18.47% -3.24% 2.10% 23.38% -17.98% 29.86% -11.46% 32.71%   
      cost of revenue:
    		                      
      total cost of revenue
    		8,245,000 10,293,000 25,246,000 8,492,000 7,845,000 8,616,000 8,328,000 8,901,000 7,380,000 29,053,000 6,039,000 7,565,000 6,387,000 9,427,000 8,629,000 8,643,000 7,232,000 11,447,000 19,743,000 8,293,000 6,027,000  
      gross profit
    		18,285,000 21,221,000 -3,757,000 14,891,000 13,380,000 13,735,000 12,233,000 12,586,000 10,276,000 -12,537,000 9,382,000 10,922,000 9,089,000 9,556,000 10,989,000 10,572,000 8,342,000 7,540,000 -5,122,000 8,220,000 6,416,000  
      yoy
    		36.66% 54.50% -130.71% 18.31% 30.21% -209.56% 30.39% 15.24% 13.06% -231.20% -14.62% 3.31% 8.95% 26.74% -314.55% 28.61% 30.02%      
      qoq
    		-13.84% -664.84% -125.23% 11.29% -2.58% 12.28% -2.80% 22.48% -181.97% -233.63% -14.10% 20.17% -4.89% -13.04% 3.94% 26.73% 10.64% -247.21% -162.31% 28.12%   
      gross margin %
    		68.92% 67.34% -17.48% 63.68% 63.04% 61.45% 59.50% 58.57% 58.20% -75.91% 60.84% 59.08% 58.73% 50.34% 56.01% 55.02% 53.56% 39.71% -35.03% 49.78% 51.56% NaN% 
      operating expenses:
    		                      
      research and development
    		9,538,000 9,320,000 8,703,000 8,315,000 9,924,000 8,825,000 8,844,000 9,411,000 10,720,000 11,207,000 12,130,000 15,626,000 16,651,000 19,124,000 23,154,000 23,220,000 23,623,000 20,002,000 21,654,000 17,088,000 15,716,000  
      sales and marketing
    		11,417,000 12,071,000 10,626,000 11,559,000 11,620,000 11,854,000 9,607,000 9,728,000 10,378,000 10,297,000 9,012,000 9,728,000 10,034,000 12,437,000 15,811,000 16,438,000 15,202,000 15,054,000 14,203,000 10,540,000 9,808,000  
      general and administrative
    		10,818,000 11,217,000 9,289,000 9,130,000 9,600,000 9,942,000 9,353,000 10,073,000 10,442,000 12,374,000 11,560,000 14,660,000 11,019,000 26,997,000 18,056,000 19,369,000 19,050,000 17,789,000 16,008,000 17,279,000 34,640,000  
      other
    		385,000 5,325,000 2,759,000 1,987,000 704,000 426,000 1,675,000 606,000 1,357,000 316,000 9,243,000 2,172,000 6,432,000          
      total operating expenses
    		32,158,000 37,933,000 31,377,000 30,991,000 31,848,000 31,047,000 29,479,000 29,818,000 32,897,000 34,194,000 41,945,000 42,186,000 44,136,000 58,558,000 57,021,000 59,027,000 57,875,000 52,845,000 51,865,000 44,907,000 60,164,000  
      income from operations
    		-13,873,000 -16,712,000 -35,134,000 -16,100,000 -18,468,000 -17,312,000 -17,246,000 -17,232,000 -22,621,000 -46,731,000 -32,563,000 -31,264,000 -35,047,000 -49,002,000 -46,032,000 -48,455,000 -49,533,000 -45,305,000 -56,987,000 -36,687,000 -53,748,000  
      yoy
    		-24.88% -3.47% 103.72% -6.57% -18.36% -62.95% -47.04% -44.88% -35.46% -4.63% -29.26% -35.48% -29.25% 8.16% -19.22% 32.08% -7.84%      
      qoq
    		-16.99% -52.43% 118.22% -12.82% 6.68% 0.38% 0.08% -23.82% -51.59% 43.51% 4.15% -10.79% -28.48% 6.45% -5.00% -2.18% 9.33% -20.50% 55.33% -31.74%   
      operating margin %
    		-52.29% -53.03% -163.50% -68.85% -87.01% -77.46% -83.88% -80.20% -128.12% -282.94% -211.16% -169.11% -226.46% -258.14% -234.64% -252.17% -318.05% -238.61% -389.76% -222.17% -431.95% NaN% 
      interest income
    		1,186,000 1,313,000 1,443,000 1,503,000 1,651,000 997,000 1,221,000 1,291,000 1,511,000 1,736,000 1,903,000 2,027,000 1,784,000 1,810,000 1,304,000 260,000 10,000 834,000 893,000 607,000 239,000  
      interest expense
    		-279,000 -390,000 -385,000 -368,000 -347,000 -333,000 -319,000 -309,000 -300,000      -2,000   -6,000  -7,000 -638,000  
      change in fair value of warrant liabilities
    		413,000 620,000 207,000 620,000 826,000 -1,033,000 -1,239,000 620,000 -207,000 620,000 3,511,000 620,000 -207,000 11,978,000 -9,087,000 12,805,000 5,163,000 30,567,000 42,958,000 33,458,000 54,112,000  
      other income
    		-124,000 -56,000 -86,000 531,000 2,378,000 -530,000 717,000  -141,000 254,000 -217,000 -60,000 17,000 1,485,000 -898,000 -388,000 -100,000 -1,257,000 -428,000 -262,000 -631,000  
      income before provision for income taxes
    		-12,677,000 -15,225,000 -33,955,000 -13,814,000 -13,960,000 -18,211,000 -16,866,000 -15,689,000 -21,758,000 -44,121,000 -27,366,000 -28,677,000 -33,453,000 -33,729,000 -54,715,000 -35,778,000 -44,460,000 -15,167,000 -13,564,000 -2,891,000 -666,000  
      provision for income taxes
    		 67,000 16,000 20,000 7,000 -110,000 58,000 17,000 3,000  2,000 -6,000 87,000 -26,000 27,000 23,000 17,000 49,000 -3,000 51,000 24,000  
      net loss and comprehensive loss
    		-12,677,000 -15,292,000 -33,971,000 -13,834,000 -13,967,000 -18,101,000 -16,924,000 -15,706,000 -21,761,000 -44,121,000 -27,368,000 -28,671,000 -33,540,000 -33,703,000 -54,742,000 -35,801,000 -44,477,000 -15,216,000 -13,561,000 -2,942,000 -690,000  
      net loss per common share attributable to class a and b common stockholders, basic and diluted
    		-50 -60 -130 -60 -60 -80 -80 -70 -100 -210 -130 -140 -170 -160 -270 -180 -220 -90 -70 -20 -10  
      weighted-average shares used for eps calculation
    		256,516,256,000 247,124,365,000 252,087,541,000 248,393,811,000 234,923,536,000 211,682,760,000 212,774,085,000 211,663,554,000 208,873,449,000 205,385,544,000 206,740,234,000 204,895,341,000 202,565,877,000 199,848,386,000 200,172,683,000 199,399,356,000 199,000,258,000 173,810,053,000 196,095,192,000 192,180,141,000 105,916,706,000  
      other expense
    		       -59,000               
      loss on product purchase commitments
    		                 2,342,000 11,623,000    
      subscription
    		               5,786,000 4,560,000 4,574,000 3,773,000 3,501,000 2,848,000  
      31.2*
    		                      
      32.1**
    		                      
      32.2**
    		                      
      101.ins*
    		                      
      101.cal*
    		                      
      101.sch*
    		                      
      101.def*
    		                      
      101.lab*
    		                      
      101.pre*
    		                      
      *
    		                      
      **
    		                      
      table of contents
    		                      
      longview acquisition corp.
    		                      
      date: november 16, 2020
    		                      
      name:
    		                      
      title:
    		                      
    Balance Sheets:
    Quarterly
    Annual
      Unit: USD2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 
                           
        assets
      		                     
        current assets:
      		                     
        cash and cash equivalents
      		137,954,000 150,489,000 144,233,000 148,136,000 155,212,000 88,775,000 93,758,000 102,051,000 112,652,000 134,437,000 150,006,000 166,806,000 193,808,000 162,561,000 193,313,000 310,802,000 359,901,000 422,841,000 153,326,000 19,605,000 18,850,000 
        accounts receivable
      		25,210,000 26,744,000 24,418,000 24,527,000 19,881,000 20,793,000 20,621,000 16,113,000 13,914,000 13,418,000 13,646,000 17,781,000 13,475,000 14,685,000 11,807,000 12,691,000 13,071,000 11,936,000 9,538,000 7,809,000 5,237,000 
        inventories
      		59,304,000 61,389,000 62,232,000 68,907,000 69,314,000 70,789,000 73,271,000 74,175,000 74,494,000 73,022,000 94,016,000 86,825,000 69,407,000 59,970,000 57,664,000 65,587,000 48,354,000 36,243,000 23,820,000 46,947,000 36,128,000 
        current portion of vendor advances
      		2,908,000 2,063,000 2,646,000 4,555,000 5,670,000 5,547,000 4,351,000 4,302,000 3,979,000 2,815,000 2,728,000 10,207,000 32,922,000 35,182,000 20,844,000 16,784,000 29,424,000 27,500,000 24,975,000 17,115,000 9,170,000 
        prepaid expenses and other current assets
      		14,413,000 8,418,000 7,862,000 7,622,000 7,306,000 6,709,000 7,492,000 7,836,000 8,234,000 7,571,000 8,189,000 10,212,000 12,912,000 9,489,000 14,291,000 19,647,000 23,556,000 13,384,000 16,753,000 9,294,000 9,358,000 
        total current assets
      		239,789,000 249,103,000 241,391,000 253,747,000 257,383,000 192,613,000 199,493,000 204,477,000 213,273,000 231,263,000 268,585,000 291,831,000 322,524,000 357,137,000 372,465,000 425,511,000 474,306,000 511,904,000 543,511,000 590,660,000 605,184,000 
        property and equipment
      		16,113,000 16,587,000 16,849,000 17,329,000 17,981,000 19,518,000 21,176,000 22,967,000 24,425,000 25,321,000 26,362,000 29,209,000 30,442,000 31,331,000 31,377,000 28,577,000 22,767,000 14,703,000 9,368,000 7,436,000 7,254,000 
        intangible assets
      		7,166,000 7,516,000 7,866,000 8,216,000 8,566,000 8,916,000 9,266,000 9,617,000 9,967,000 10,317,000            
        non-current portion of vendor advances
      		4,970,000 5,008,000 5,114,000 14,790,000 14,890,000 15,042,000 15,082,000 15,185,000 15,169,000 15,276,000 16,808,000 15,441,000   9,883,000 12,168,000 7,452,000 12,782,000 20,601,000 26,365,000 32,535,000 
        operating lease assets
      		12,233,000 12,652,000 13,061,000 13,461,000 13,852,000 14,233,000 14,606,000 14,970,000 15,325,000 15,675,000 16,016,000 20,566,000 21,092,000 21,567,000 22,146,000 22,981,000 23,524,000 24,083,000    
        other non-current assets
      		5,651,000 5,667,000 5,721,000 5,735,000 5,740,000 5,760,000 5,649,000 5,851,000 6,129,000 6,422,000 6,451,000 7,541,000 7,623,000 7,535,000 7,387,000 7,400,000 7,371,000 8,493,000 6,838,000 6,802,000 2,505,000 
        total assets
      		285,922,000 296,533,000 290,002,000 313,278,000 318,412,000 256,082,000 265,272,000 273,067,000 284,288,000 304,274,000 334,222,000 364,588,000 381,681,000 417,570,000 443,258,000 496,637,000 535,420,000 571,965,000 580,318,000 631,263,000 647,478,000 
        liabilities and stockholders’ equity
      		                     
        current liabilities:
      		                     
        accounts payable
      		2,817,000 5,442,000 3,308,000 3,320,000 2,277,000 4,250,000 3,651,000 4,514,000 5,808,000 5,090,000 8,097,000 8,386,000 5,429,000 7,211,000 2,675,000 3,518,000 2,683,000 5,798,000 5,017,000 5,264,000 5,268,000 
        deferred revenue, current
      		22,659,000 26,909,000 16,379,000 15,642,000 15,385,000 16,139,000 16,425,000 14,751,000 14,464,000 15,625,000 15,117,000 13,725,000 14,933,000 15,856,000 13,927,000 15,572,000 13,359,000 13,071,000 12,015,000 10,894,000 9,548,000 
        accrued purchase commitments, current
      		131,000 131,000 131,000 131,000 131,000 131,000 131,000 131,000 131,000 131,000 212,000 531,000 531,000 2,146,000 3,951,000 18,119,000 5,743,000 5,329,000 5,329,000 22,890,000 22,890,000 
        warrant liabilities, current
      		 413,000 1,033,000 1,239,000 1,859,000                 
        accrued expenses and other current liabilities
      		33,973,000 32,222,000 29,480,000 24,334,000 22,824,000 27,695,000 22,585,000 21,386,000 21,139,000 23,425,000 21,933,000 23,197,000 23,897,000 26,116,000 25,327,000 24,998,000 28,922,000 25,631,000 22,809,000 19,327,000 14,666,000 
        total current liabilities
      		59,580,000 65,117,000 50,331,000 44,666,000 42,476,000 48,215,000 42,792,000 40,782,000 41,542,000 44,271,000 45,359,000 45,839,000 44,790,000 51,329,000 45,880,000 62,207,000 50,707,000 49,829,000 45,170,000 58,375,000 52,372,000 
        deferred revenue, non-current
      		9,631,000 9,391,000 7,907,000 7,231,000 7,599,000 7,315,000 7,035,000 7,360,000 7,217,000 7,394,000 5,273,000 6,026,000 4,344,000 4,957,000 5,591,000 6,954,000 6,272,000 5,476,000 4,878,000 4,840,000 4,014,000 
        operating lease liabilities
      		17,017,000 17,721,000 18,414,000 19,097,000 19,757,000 20,398,000 21,030,000 21,652,000 22,252,000 22,835,000 23,409,000 28,699,000 29,440,000 29,966,000 30,176,000 30,422,000 30,097,000 27,690,000    
        other non-current liabilities
      		8,472,000 8,325,000 9,520,000 9,478,000 8,884,000 8,637,000 10,931,000 8,580,000 8,240,000 8,895,000 1,316,000 1,362,000 1,384,000 588,000 626,000 694,000 828,000 850,000 8,013,000 2,282,000 2,055,000 
        total liabilities
      		94,700,000 100,554,000 86,172,000 80,472,000 78,716,000 87,250,000 83,440,000 78,787,000 80,284,000 84,221,000 76,803,000 86,883,000 85,534,000 92,210,000 99,621,000 109,948,000 122,756,000 124,274,000 129,057,000 184,911,000 211,315,000 
        commitments and contingencies
      		                     
        stockholders’ equity:
      		                     
        class a common stock .0001 par value...
      		23,000 23,000 23,000 22,000 22,000 19,000 19,000 19,000 18,000 18,000 18,000 18,000 18,000 17,000 17,000 17,000 17,000 17,000 17,000 17,000 16,000 
        class b common stock .0001 par value...
      		3,000 3,000 3,000 3,000 3,000 3,000 3,000 3,000 3,000 3,000 3,000 3,000 3,000 3,000 3,000 3,000 3,000 3,000 3,000 3,000 3,000 
        additional paid-in capital
      		1,083,067,000 1,075,147,000 1,067,706,000 1,062,712,000 1,055,768,000 970,940,000 965,839,000 961,363,000 955,382,000 949,670,000 942,915,000 935,833,000 925,604,000 921,278,000 905,852,000 894,162,000 884,336,000 874,886,000 863,240,000 844,770,000 831,640,000 
        accumulated deficit
      		-891,871,000 -879,194,000 -863,902,000 -829,931,000 -816,097,000 -802,130,000 -784,029,000 -767,105,000 -751,399,000 -729,638,000 -685,517,000 -658,149,000 -629,478,000 -595,938,000 -562,235,000 -507,493,000 -471,692,000 -427,215,000 -411,999,000 -398,438,000 -395,496,000 
        total stockholders’ equity
      		191,222,000 195,979,000 203,830,000 232,806,000 239,696,000 168,832,000 181,832,000 194,280,000 204,004,000 220,053,000 257,419,000 277,705,000 296,147,000 325,360,000 343,637,000 386,689,000 412,664,000 447,691,000 451,261,000 446,352,000 436,163,000 
        total liabilities and stockholders’ equity
      		285,922,000 296,533,000 290,002,000 313,278,000 318,412,000 256,082,000 265,272,000 273,067,000 284,288,000 304,274,000 334,222,000 364,588,000 381,681,000 417,570,000 443,258,000 496,637,000 535,420,000     
        warrant liabilities, non-current
      		                     
        warrant liabilities
      		     2,685,000 1,652,000 413,000 1,033,000 826,000 1,446,000 4,957,000 5,576,000 5,370,000 17,348,000 8,261,000 21,066,000 26,229,000 56,796,000 99,754,000 133,214,000 
        marketable securities
      		             75,250,000 74,546,000    315,099,000 489,890,000 526,441,000 
        accrued purchase commitments, non-current
      		               1,410,000 13,786,000 14,200,000 14,200,000 19,660,000 19,660,000 
        liabilities, convertible preferred stock and stockholders’ equity
      		                     
        convertible debt
      		                     
        loan payable
      		                     
        convertible preferred stock:
      		                     
        convertible preferred stock (series a, b, c and d) .0001 par value with an aggregate liquidation preference of 0 and 383,829 at december 31, 2021 and 2020, respectively; 0 and 107,197,118 shares authorized, issued and outstanding at december 31, 2021 and 2020, respectively
      		                     
        stockholders’ equity
      		                     
        total liabilities, convertible preferred stock and stockholders’ equity
      		                 571,965,000 580,318,000 631,263,000 647,478,000 
        convertible preferred stock (series a, b, c and d) .0001 par value with an aggregate liquidation preference of 0 and 383,829 at september 30, 2021 and december 31, 2020, respectively; 0 and 107,197,118 shares authorized, issued and outstanding at september 30, 2021 and december 31, 2020, respectively
      		                     
        convertible preferred stock (series a, b, c and d) .0001 par value with an aggregate liquidation preference of 0 and 383,829 at june 30, 2021 and december 31, 2020, respectively; 0 and 107,197,118 shares authorized, issued and outstanding at june 30, 2021 and december 31, 2020, respectively
      		                     
        convertible preferred stock (series a, b, c and d) .0001 par value with an aggregate liquidation preference of 0 and 383,829 at march 31, 2021 and december 31, 2020, respectively; 0 and 107,197,118 shares authorized, issued and outstanding at march 31, 2021 and december 31, 2020, respectively
      		                     
      Cashflow Statements:
      Quarterly
      Annual
        Unit: USD2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 
                             
          cash flows from operating activities:
        		                     
          net loss
        		-12,677,000 -15,292,000 -33,971,000 -13,834,000 -13,967,000 -18,101,000 -16,924,000 -15,706,000 -21,761,000 -44,121,000 -27,368,000 -28,671,000 -33,540,000 -33,703,000 -54,742,000 -35,801,000 -44,477,000 -15,216,000 -13,561,000 -2,942,000 -690,000 
          adjustments to reconcile net loss to net cash from operating activities:
        		                     
          depreciation, amortization, and impairments
        		1,811,000 1,754,000 1,885,000 2,082,000 2,360,000 2,507,000 2,618,000 2,633,000 2,584,000 2,242,000            
          non-cash interest expense
        		280,000 391,000 386,000 367,000 346,000 330,000 319,000 308,000 299,000             
          write-down of inventories
        		 44,000 7,865,000 14,000 52,000 0 96,000 0 -81,000         307,000    
          stock-based compensation expense
        		5,542,000 6,361,000 4,926,000 5,864,000 6,284,000 5,238,000 4,411,000 5,859,000 5,524,000 6,556,000 6,815,000 9,924,000 4,185,000 15,103,000 9,413,000 9,285,000 8,730,000 9,029,000 10,734,000 7,737,000 20,298,000 
          change in fair value of warrant liabilities
        		-413,000 -620,000 -206,000 -620,000 -826,000 1,033,000 1,239,000 -620,000 207,000 -620,000 -3,511,000 -620,000 207,000 -11,978,000 9,087,000 -12,805,000 -5,163,000 -30,567,000 -42,958,000 -33,458,000 -54,112,000 
          other
        		137,000 453,000 174,000 116,000 56,000 157,000 483,000 218,000 244,000 1,111,000 173,000 57,000 -708,000 -135,000 613,000 97,000 40,000 1,235,000 167,000 101,000 397,000 
          changes in operating assets and liabilities:
        		                     
          accounts receivable
        		1,409,000 -2,781,000 -63,000 -4,766,000 857,000 -345,000 -4,993,000 -2,414,000 -751,000 -873,000 4,004,000 -4,370,000 1,077,000 -3,024,000 870,000 270,000 -1,179,000 -2,453,000 -1,695,000 -2,564,000 585,000 
          inventories
        		2,085,000 799,000 -1,190,000 393,000 1,423,000 2,482,000 808,000 319,000 -1,391,000 -89,000 -7,191,000 -17,418,000 -9,437,000 -3,089,000 7,923,000 -17,233,000 -12,111,000 -12,717,000 22,545,000 -10,789,000 -10,324,000 
          prepaid expenses and other assets
        		-5,979,000 -502,000 -240,000 -304,000 -570,000 623,000 516,000 541,000 -376,000 625,000 2,969,000 2,560,000 -3,175,000 4,317,000 2,995,000 1,962,000 -5,455,000 -1,773,000 -2,544,000 -238,000 -6,114,000 
          vendor advances
        		-807,000 689,000 1,964,000 1,215,000 29,000 -1,156,000 54,000 -339,000 -1,057,000 1,445,000 6,112,000 7,274,000 2,260,000 -4,455,000 -1,775,000 7,924,000 3,406,000 2,994,000 -2,096,000 -1,775,000 -1,744,000 
          accounts payable
        		-2,643,000 2,138,000 -16,000 1,043,000 -1,970,000 599,000 -853,000 -1,290,000 703,000 -2,967,000 -298,000 2,951,000 -1,561,000 4,337,000 -684,000 739,000 -3,176,000 755,000 -188,000 -88,000 -11,000,000 
          deferred revenue
        		-4,010,000 12,014,000 1,413,000 -111,000 -470,000 -6,000 1,349,000 430,000 -1,338,000 2,629,000 639,000 474,000 -1,536,000 1,295,000 -3,008,000 2,895,000 1,084,000 1,654,000 1,159,000 2,172,000 2,329,000 
          change in operating lease assets and liabilities
        		-222,000 -222,000 -222,000 -210,000 -201,000 -201,000 -201,000 -185,000 -163,000 36,000 -867,000 21,000 175,000 485,000 654,000 496,000 622,000     
          accrued expenses and other liabilities
        		1,593,000 3,805,000 4,787,000 1,584,000 -5,080,000 3,720,000 3,158,000 246,000 -3,310,000 -77,000 -952,000 -862,000 -1,695,000 1,141,000 329,000 -3,175,000 2,606,000 -854,000 3,890,000 4,885,000 -3,899,000 
          net cash from operating activities
        		-13,894,000 9,031,000 -2,887,000 -7,167,000 -11,677,000 -3,120,000 -7,920,000 -10,000,000 -20,667,000 -13,101,000 -15,981,000 -26,486,000 -43,252,000 -28,859,000 -42,027,000 -43,995,000 -54,234,000 -42,777,000 -46,481,000 -36,502,000 -63,427,000 
          capital expenditures
        		-950,000 -1,083,000 -1,016,000 -896,000 -353,000 -408,000 -414,000 -734,000 -1,138,000 0 -1,048,000 -881,000 -1,342,000 -2,122,000 -4,602,000 -7,072,000 -4,506,000 -4,051,000 -1,997,000 -540,000 -1,289,000 
          free cash flows
        		-14,844,000 7,948,000 -3,903,000 -8,063,000 -12,030,000 -3,528,000 -8,334,000 -10,734,000 -21,805,000 -13,101,000 -17,029,000 -27,367,000 -44,594,000 -30,981,000 -46,629,000 -51,067,000 -58,740,000 -46,828,000 -48,478,000 -37,042,000 -64,716,000 
          cash flows from investing activities:
        		                     
          purchases of property, equipment, and intangible assets, including capitalized software
        		-950,000 -1,083,000 -1,016,000 -896,000 -353,000 -408,000 -414,000 -734,000 -1,138,000             
          net cash from investing activities
        		-950,000 -1,083,000 -1,016,000 -896,000 -353,000 -408,000 -413,000 -699,000 -1,138,000 -2,512,000 -1,048,000 -881,000 74,855,000 -2,481,000 -79,720,000 -7,072,000 -4,506,000 309,899,000 172,574,000 35,854,000 -528,197,000 
          cash flows from financing activities:
        		                     
          proceeds from exercise of stock options
        		2,309,000 542,000                   6,283,000 
          net proceeds from share offering
        		 0 0 -103,000 81,109,000                 
          payments to tax authorities for restricted stock units withheld
        		 -9,000 0 0 -2,775,000                 
          net cash from financing activities
        		2,309,000 -1,692,000 0 987,000 78,467,000     0 92,000   137,000 2,035,000 159,000 550,000 2,393,000 7,628,000 5,403,000 550,268,000 
          net increase in cash, cash equivalents, and restricted cash
        		-12,535,000 6,256,000 -3,903,000 -7,076,000 66,437,000   -10,699,000 -21,805,000             
          cash, cash equivalents, and restricted cash, beginning of period
        		154,504,000 0 0 0 92,790,000 0 0 0 138,650,000 0 0 0 166,828,000         
          cash, cash equivalents, and restricted cash, end of period
        		141,969,000 6,256,000 -3,903,000 -7,076,000 159,227,000 -5,023,000 -8,333,000 -10,699,000 116,845,000 -15,613,000 -16,937,000 -27,231,000 198,431,000         
          write-down of vendor advances
        		 0                    
          gain on lease termination
        		         0            
          accrued purchase commitments
        		         -81,000 -319,000 0 -1,615,000 -1,805,000    -42,000    
          purchases of marketable securities
        		         0 0 0 -297,000 -416,000    -908,000 -325,581,000 -606,000 -691,908,000 
          sales of marketable securities
        		         0 0 0 76,484,000     314,858,000 500,152,000 37,000,000 165,000,000 
          sales of property and equipment
        		     0 1,000   0 0 0 10,000         
          proceeds from employee stock purchase plan
        		 466,000 0                   
          payments on technology license commitment
        		                     
          supplementary cash flow disclosures:
        		                     
          interest paid
        		                     
          non-cash investing and financing activities:
        		                     
          acquisition of property, equipment, and intangible assets, including capitalized software
        		                     
          proceeds from exercise of stock options and warrants
        		   141,000 133,000     0 92,000   138,000 2,034,000 159,000 651,000 2,393,000 7,628,000   
          net decrease in cash, cash equivalents, and restricted cash
        		     -5,023,000                
          supplementary disclosure of non-cash investing and financing activities
        		                     
          write-down of vendor advance
        		                     
          non-cash interest expense on convertible debt
        		                 0 0 0 389,000 
          net proceeds from equity infusion from the business combination
        		                 0 0 0 548,403,000 
          payment of loan payable
        		                 0 0 0 -4,366,000 
          payments of debt issuance costs
        		                 0 0 0 -52,000 
          other financing activities
        		             -1,000 1,000 0 -101,000     
          purchases of property and equipment, including capitalized software
        		          -1,048,000 -881,000 -1,342,000 -2,122,000 -4,602,000 -7,072,000 -4,506,000     
          depreciation and amortization
        		           2,194,000 2,111,000 1,869,000 1,876,000 1,351,000 839,000 670,000 505,000 457,000 458,000 
          net increase in cash, cash equivalents and restricted cash
        		            31,603,000 -31,203,000 -119,712,000 -50,908,000 -58,190,000 269,515,000 133,721,000   
          proceeds from loan payable
        		                     
          proceeds from issuance of convertible debt
        		                     
          cash, cash equivalents and restricted cash, beginning of period
        		             0 0 0 426,841,000 0 0   
          cash, cash equivalents and restricted cash, end of period
        		             -31,203,000 -119,712,000 -50,908,000 368,651,000 269,515,000 133,721,000   
          purchase of property and equipment
        		                     
          deferred offering costs and debt issuance costs
        		                     
          purchases of property and equipment
        		                 -4,051,000 -1,997,000 -540,000 -1,289,000 
          reconciliation of cash, cash equivalents and restricted cash reported within the condensed consolidated balance sheets
        		                     
          cash and cash equivalents
        		                 269,515,000 133,721,000   
          restricted cash
        		                 0 0   
          total cash, cash equivalents and restricted cash shown in the statement of cash flows
        		                 269,515,000 133,721,000   
          net increase in cash and cash equivalents
        		                    -41,356,000 
          cash and cash equivalents, beginning of period
        		                    60,206,000 
          cash and cash equivalents, end of period
        		                    18,850,000